|
Friday 14th February 2003 |
Text too small? |
Even so the dental and medical software maker's revenues are growing fast and it will no doubt come back into fashion once it shows it can keep costs in check and pump out earnings at the bottom line.
The shares were listed in December 2000 after a float at $1. The prospectus forecast March 2002-year revenue of $14.6 million and a $2.4 million net profit. It didn't make either; revenue was only slightly off at $13.7 million but it lost $191,000.
The company is picking a breakeven result for the March 2003 year after losing $1.43 million in the first half.
Following the $2.5 million acquisition of Advanced Healthcare Computing, Britain now accounts for more than 83% of group revenues. The company is also on a major sales push into the US, with modest results so far, and its dental software is in use in Australia, Singapore, Malaysia, Ireland, Kuwait, Saudi Arabia and Dubai.
It has also moved into the optometry software market with a contract to supply the local Visique chain.
A November rights issue aimed at raising $6.2 million brought in only $4.3 million but the company is debt-free. The main indicator to watch in the upcoming result will be operating cashflow.
No comments yet
SPK - Spark announces appointment of Chief Operating Officer
SKC - Asset Monetisation Programme Update - The Grand Hotel
VCT - Full year results date & investor webcast details
ANZ - Air New Zealand 2026 Annual Results Webcast Details
SKC - Asset Monetisation Programme Update
July 17th Morning Report
MEL - Meridian Energy monthly operating report for June 2026
Devon Funds Morning Note - 15 July 2026
BIT - Transaction in Own Shares
Summerset Welcomes Alison Barrass to Board